HomeCompareSRHGF vs JNJ

SRHGF vs JNJ: Dividend Comparison 2026

SRHGF yields 2.92% · JNJ yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SRHGF wins by $361.99M in total portfolio value
10 years
SRHGF
SRHGF
● Live price
2.92%
Share price
$14.72
Annual div
$0.43
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$362.02M
Annual income
$339,651,558.84
Full SRHGF calculator →
JNJ
Johnson & Johnson
● Live price
2.13%
Share price
$244.44
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$4,689.40
Full JNJ calculator →

Portfolio growth — SRHGF vs JNJ

📍 SRHGF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSRHGFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SRHGF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SRHGF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SRHGF
Annual income on $10K today (after 15% tax)
$247.94/yr
After 10yr DRIP, annual income (after tax)
$288,703,825.01/yr
JNJ
Annual income on $10K today (after 15% tax)
$180.82/yr
After 10yr DRIP, annual income (after tax)
$3,985.99/yr
At 15% tax rate, SRHGF beats the other by $288,699,839.02/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SRHGF + JNJ for your $10,000?

SRHGF: 50%JNJ: 50%
100% JNJ50/50100% SRHGF
Portfolio after 10yr
$181.03M
Annual income
$169,828,124.12/yr
Blended yield
93.81%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

SRHGF
No analyst data
Altman Z
5.6
Piotroski
5/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-6.4% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SRHGF buys
0
JNJ buys
8
PoliticianChamberTickerTypeAmountDate
Thomas H. Kean🏢 House$JNJ▼ Sell$15,001 - $50,0002026-01-23
Julie Johnson🏢 House$JNJ▼ Sell$1,001 - $15,0002025-12-18
Lloyd Doggett🏢 House$JNJ▲ Buy$1,001 - $15,0002025-12-09
Thomas H. Kean🏢 House$JNJ▼ Sell$15,001 - $50,0002025-11-20
Julie Johnson🏢 House$JNJ▼ Sell$1,001 - $15,0002025-11-13
Rich McCormick🏢 House$JNJ▲ Buy$1,001 - $15,0002025-11-05
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Jared Moskowitz🏢 House$JNJ▼ Sell$1,001 - $15,0002025-10-10
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSRHGFJNJ
Forward yield2.92%2.13%
Annual dividend / share$0.43$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%28%
Portfolio after 10y$362.02M$30.3K
Annual income after 10y$339,651,558.84$4,689.40
Total dividends collected$360.35M$15.4K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: SRHGF vs JNJ ($10,000, DRIP)

YearSRHGF PortfolioSRHGF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,283$583.40$10,592$272.30+$691.00SRHGF
2$13,304$1,230.41$11,289$357.73+$2.0KSRHGF
3$16,947$2,711.61$12,123$472.89+$4.8KSRHGF
4$24,589$6,456.29$13,141$629.86+$11.4KSRHGF
5$43,820$17,510.18$14,408$846.81+$29.4KSRHGF
6$105,215$58,327.33$16,021$1,151.60+$89.2KSRHGF
7$374,350$261,770.04$18,122$1,588.22+$356.2KSRHGF
8$2,141,423$1,740,867.65$20,930$2,228.20+$2.12MSRHGF
9$20,905,168$18,613,845.48$24,792$3,191.91+$20.88MSRHGF
10$362,020,088$339,651,558.84$30,274$4,689.40+$361.99MSRHGF

SRHGF vs JNJ: Complete Analysis 2026

SRHGFStock

Shoprite Holdings Ltd, an investment holding company, primarily engages in the food retailing and wholesaling business in South Africa and internationally. The company operates through four segments: Supermarkets RSA, Supermarkets Non-RSA, Furniture, and Other Operating segments. It also offers clothing, general merchandise, cosmetic, and liquor products; furniture and home entertainment; and electrical and household appliances. In addition, the company distributes various pharmaceutical products and surgical equipment to pharmacies, hospitals, clinics, dispensing doctors, and veterinary surgeons. it operates 2,989 stores under the Shoprite, Checkers, Checkers Hyper, Usave, Shoprite LiquorShop, Checkers LiquorShop, House & Home, OK Furniture & Power Express, MediRite Pharmacy, TransPharm, Computicket, Computicket Travel, Checkers Food Services, k'nect, OK Foods, OK Grocer, OK MiniMark, OK Express, Sentra, OK Liquor, and Megasave brands. Further, the company provides flight ticketing, and car rental and accommodation services; stadium management, capacity management, travel management, and access control solutions; and financial services and treasury management services. Shoprite Holdings Limited was founded in 1979 and is based in Brackenfell, South Africa.

Full SRHGF Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this SRHGF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SRHGF vs SCHDSRHGF vs JEPISRHGF vs OSRHGF vs KOSRHGF vs MAINSRHGF vs ABBVSRHGF vs MRKSRHGF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.